10/19/2005 5:08:56 PM
AltaRex Medical Corp. (TSX:ALT) ("AltaRex" or the "Company") today announced that the Company has signed an exclusive distribution agreement (the "Agreement") with Dompe International S.A. (Lausanne, Switzerland) ("Dompe") for its lead product OvaRex(R) MAb. The territory of the Agreement includes Italy, Spain, Portugal, Hungary, Poland, Czech Republic, Switzerland, Austria as well as other Eastern European countries. The Agreement grants Dompe certain rights of first refusal for certain additional cancer antibodies in the territory such as BrevaRex(R), AR 54, ProstaRex(R) and GivaRex(R). The Agreement resulted from a memorandum of understanding (the "MOU") entered into between AltaRex and Dompe on November 16, 2000.
comments powered by